• Skip to content (access key 1)
  • Skip to search (access key 7)
FWF — Austrian Science Fund
  • Go to overview page Discover

    • Research Radar
    • Discoveries
      • Emmanuelle Charpentier
      • Adrian Constantin
      • Monika Henzinger
      • Ferenc Krausz
      • Wolfgang Lutz
      • Walter Pohl
      • Christa Schleper
      • Anton Zeilinger
    • scilog Magazine
    • Awards
      • FWF Wittgenstein Awards
      • FWF START Awards
    • excellent=austria
      • Clusters of Excellence
      • Emerging Fields
    • In the Spotlight
      • 40 Years of Erwin Schrödinger Fellowships
      • Quantum Austria
    • Dialogs and Talks
      • think.beyond Summit
    • E-Book Library
  • Go to overview page Funding

    • Portfolio
      • excellent=austria
        • Clusters of Excellence
        • Emerging Fields
      • Projects
        • Principal Investigator Projects
        • Principal Investigator Projects International
        • Clinical Research
        • 1000 Ideas
        • Arts-Based Research
        • FWF Wittgenstein Award
      • Careers
        • ESPRIT
        • FWF ASTRA Awards
        • Erwin Schrödinger
        • Elise Richter
        • Elise Richter PEEK
        • doc.funds
        • doc.funds.connect
      • Collaborations
        • Specialized Research Groups
        • Special Research Areas
        • Research Groups
        • International – Multilateral Initiatives
        • #ConnectingMinds
      • Communication
        • Top Citizen Science
        • Science Communication
        • Book Publications
        • Digital Publications
        • Open-Access Block Grant
      • Subject-Specific Funding
        • AI Mission Austria
        • Belmont Forum
        • ERA-NET HERA
        • ERA-NET NORFACE
        • ERA-NET QuantERA
        • ERA-NET TRANSCAN
        • Alternative Methods to Animal Testing
        • European Partnership Biodiversa+
        • European Partnership ERA4Health
        • European Partnership ERDERA
        • European Partnership EUPAHW
        • European Partnership FutureFoodS
        • European Partnership OHAMR
        • European Partnership PerMed
        • European Partnership Water4All
        • Gottfried and Vera Weiss Award
        • netidee SCIENCE
        • Herzfelder Foundation Projects
        • Quantum Austria
        • Rückenwind Funding Bonus
        • Zero Emissions Award
      • International Collaborations
        • Belgium/Flanders
        • Germany
        • France
        • Italy/South Tyrol
        • Japan
        • Luxembourg
        • Poland
        • Switzerland
        • Slovenia
        • Taiwan
        • Tyrol–South Tyrol–Trentino
        • Czech Republic
        • Hungary
    • Step by Step
      • Find Funding
      • Submitting Your Application
      • International Peer Review
      • Funding Decisions
      • Carrying out Your Project
      • Closing Your Project
      • Further Information
        • Integrity and Ethics
        • Inclusion
        • Applying from Abroad
        • Personnel Costs
        • PROFI
        • Final Project Reports
        • Final Project Report Survey
    • FAQ
      • Project Phase PROFI
        • Accounting for Approved Funds
        • Labor and Social Law
        • Project Management
      • Project Phase Ad Personam
        • Accounting for Approved Funds
        • Labor and Social Law
        • Project Management
      • Expiring Programs
        • FWF START Awards
  • Go to overview page About Us

    • Mission Statement
    • FWF Video
    • Values
    • Facts and Figures
    • Annual Report
    • What We Do
      • Research Funding
        • Matching Funds Initiative
      • International Collaborations
      • Studies and Publications
      • Equal Opportunities and Diversity
        • Objectives and Principles
        • Measures
        • Creating Awareness of Bias in the Review Process
        • Terms and Definitions
        • Your Career in Cutting-Edge Research
      • Open Science
        • Open Access Policy
          • Open Access Policy for Peer-Reviewed Publications
          • Open Access Policy for Peer-Reviewed Book Publications
          • Open Access Policy for Research Data
        • Research Data Management
        • Citizen Science
        • Open Science Infrastructures
        • Open Science Funding
      • Evaluations and Quality Assurance
      • Academic Integrity
      • Science Communication
      • Philanthropy
      • Sustainability
    • History
    • Legal Basis
    • Organization
      • Executive Bodies
        • Executive Board
        • Supervisory Board
        • Assembly of Delegates
        • Scientific Board
        • Juries
      • FWF Office
    • Jobs at FWF
  • Go to overview page News

    • News
    • Press
      • Logos
    • Calendar
      • Post an Event
      • FWF Informational Events
    • Job Openings
      • Enter Job Opening
    • Newsletter
  • Discovering
    what
    matters.

    FWF-Newsletter Press-Newsletter Calendar-Newsletter Job-Newsletter scilog-Newsletter

    SOCIAL MEDIA

    • LinkedIn, external URL, opens in a new window
    • Twitter, external URL, opens in a new window
    • Facebook, external URL, opens in a new window
    • Instagram, external URL, opens in a new window
    • YouTube, external URL, opens in a new window

    SCILOG

    • Scilog — The science magazine of the Austrian Science Fund (FWF)
  • elane login, external URL, opens in a new window
  • Scilog external URL, opens in a new window
  • de Wechsle zu Deutsch

  

Personalized Optimization of MNETs-Lu177 Therapy (POPEYE)

Personalized Optimization of MNETs-Lu177 Therapy (POPEYE)

Erich Griessler (ORCID: 0000-0003-4129-8168)
  • Grant DOI 10.55776/I4732
  • Funding program International - Multilateral Initiatives
  • Status ended
  • Start May 1, 2020
  • End October 31, 2023
  • Funding amount € 266,410
  • Project website
  • E-mail

ERA-NET: Permed

Disciplines

Other Social Sciences (25%); Sociology (50%); Economics (25%)

Keywords

    Responsible Research and Innovation, Ethical Legal and Social Aspects

Abstract Final report

The POPEYE project uses advanced computational tools for the optimization of midgut neuroendocrine tumors (MNETs) treatment, towards the personalization of 177Lu therapeutic protocols. MNETs constitute the largest group of gastrointestinal NETs and they are the second most-common small bowel malignancy. Establishing prognosis and guiding patients about the most appropriate course of therapy are both challenging. An interdisciplinary approach exploits established tools and novel developments to increase the early, effective diagnosis and the efficacy of 177Lu radionuclide therapy. MC simulations incorporating ML techniques serve as gold standard and allows to estimate dosimetry on personalized treatment protocols. A well-established management & dissemination plan in combination with an extensive research on economic, ethical, legal and social aspects will allow to achieve POPEYEs final goal; the clinical evaluation and exploitation of the proposed software & hardware tools, as a support guidance to the clinicians, to assess personalized MNETS diagnosis and therapy protocols.

The POPEYE project uses advanced computational tools to optimize the treatment of Midgut Neuroendocrine Tumors (MNETs) to personalize 177Lu radionuclide therapy protocols. MNETs are the largest group of gastrointestinal NETs. They are the second most common malignancy of the small intestine. Establishing a prognosis and informing patients about the most appropriate course of therapy is a challenge. An interdisciplinary approach uses established tools and novel developments to improve the early, effective diagnosis and efficacy of 177Lu radionuclide therapy. Monte Carlo simulations using machine learning techniques serve as the gold standard and enable estimation of dosimetry using personalized treatment protocols tailored to the individual patient. A well-established management and dissemination plan combined with a comprehensive study of the economic, ethical, legal and social aspects of the new therapy will allow to achieve the goal of POPEYE: the clinical evaluation and use of the proposed software and hardware tools to support physicians in the evaluation of personalized MNETS diagnostic and therapeutic protocols. The FWF-funded sub-project of the POPEYE project "Research on the social and economic impact of the proposed personalized methodology and its embedment in health care system" investigated the economic, ethical, legal, and social aspects of the new therapeutic approach using qualitative social science and economic methods. At the beginning of the project, we conducted an overview of the relevant literature and found that there is currently little research on MNET patients and their perspective on radionuclide therapy. We then conducted empirical, qualitative studies in France and Greece to close the research gap. Interviews with nuclear medicine professionals, nurses and hospital managers, and other professionals as well as patients have shown the close link between the activities of professionals aiming to organize radionuclide therapy by, among other things, trying to contain the radiation risk ("taming risk") and the creation of trust among patients in therapy and professionals. Our qualitative research has highlighted social inequalities in access to radionuclide therapy treatment and analyzed patients' experiences and perspectives on treatment. Access to radionuclide therapy is unsystematic and characterized by long and complex treatment paths. An important experience for patients is that they and their needs are taken care of, e.g. by contact persons and by responding to individual needs. An initial cost analysis within the project points to the benefits of treatment, but also to high costs for hospitals, insurance companies, patients, and society. The cooperation between the natural and social sciences in the POPEYE project, which enables a comprehensive assessment of a new treatment method, clearly demonstrates the advantages of interdisciplinary cooperation between the natural and social sciences.

Research institution(s)
  • Institut für Höhere Studien - IHS - 100%
International project participants
  • David Sarrut, Universite Claude Bernard Lyon 1 - France
  • Dimitris Visvikis, University of Brest - France
  • Panagiotis Papadimitroulas, Bioemission Technology Solutions IKE - Greece
  • George C. Kagadis, University of Patras - Greece

Research Output

  • 5 Citations
  • 3 Publications
  • 1 Disseminations
Publications
  • 2025
    Title Dealing with radiation risks in systemic cancer treatment: Perspectives of practitioners and patients in French hospitals
    DOI 10.1371/journal.pone.0316998
    Type Journal Article
    Author Thircuir S
    Journal PLOS One
    Link Publication
  • 2025
    Title Navigating care: understanding cancer patients’ experiences with systemic radionuclide therapy
    DOI 10.1007/s00520-025-09380-2
    Type Journal Article
    Author Starkbaum J
    Journal Supportive Care in Cancer
    Pages 325
    Link Publication
  • 2022
    Title Ethical, Legal and Social Aspects of Precision Medicine
    DOI 10.1007/978-981-19-5082-7_11
    Type Book Chapter
    Author Alvarez M
    Publisher Springer Nature
    Pages 179-196
Disseminations
  • 0
    Title Peer Evaluation
    Type A formal working group, expert panel or dialogue

Discovering
what
matters.

Newsletter

FWF-Newsletter Press-Newsletter Calendar-Newsletter Job-Newsletter scilog-Newsletter

Contact

Austrian Science Fund (FWF)
Georg-Coch-Platz 2
(Entrance Wiesingerstraße 4)
1010 Vienna

office(at)fwf.ac.at
+43 1 505 67 40

General information

  • Job Openings
  • Jobs at FWF
  • Press
  • Philanthropy
  • scilog
  • FWF Office
  • Social Media Directory
  • LinkedIn, external URL, opens in a new window
  • Twitter, external URL, opens in a new window
  • Facebook, external URL, opens in a new window
  • Instagram, external URL, opens in a new window
  • YouTube, external URL, opens in a new window
  • Cookies
  • Whistleblowing/Complaints Management
  • Accessibility Statement
  • Data Protection
  • Acknowledgements
  • Social Media Directory
  • © Österreichischer Wissenschaftsfonds FWF
© Österreichischer Wissenschaftsfonds FWF